Table 12_2_15.1
Adverse events in patients receiving knee joint replacement, United States, 2002-2007 and 2009a
|
|
2009 |
2007 |
2006 |
2005 |
2004 |
2003 |
2002 |
Population group |
Sample size |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Percent |
SE |
Total |
|
1,460 |
3.3 |
0.5 |
2.1 |
0.6 |
4.0 |
0.8 |
3.2 |
0.7 |
5.0 |
0.9 |
5.7 |
1.0 |
8.1 |
0.9 |
Age |
Under 65 |
614 |
2.4 |
0.6 |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
65-74 |
501 |
3.6 |
0.8 |
DSU |
DSU |
4.4 |
1.1 |
DSU |
DSU |
4.5 |
1.2 |
5.5 |
1.4 |
7.4 |
1.2 |
75-84 |
309 |
4.5 |
1.2 |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
5.2 |
1.5 |
DSU |
DSU |
10.1 |
1.6 |
85 and over |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
Gender |
Male |
527 |
3.0 |
0.8 |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
4.9 |
1.4 |
10.6 |
2.3 |
8.3 |
1.6 |
Female |
933 |
3.4 |
0.6 |
DSU |
DSU |
4.0 |
1.0 |
3.3 |
0.8 |
5.0 |
1.1 |
3.1 |
0.9 |
8.0 |
1.1 |
Race |
White |
1,269 |
3.5 |
0.5 |
2.1 |
0.6 |
3.9 |
0.8 |
3.2 |
0.7 |
5.0 |
0.9 |
5.7 |
1.1 |
7.7 |
0.9 |
Black |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
Other |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
Diabetes |
Yes |
368 |
5.4 |
1.2 |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
9.4 |
2.3 |
No |
1,092 |
2.6 |
0.5 |
2.5 |
0.7 |
3.9 |
0.9 |
3.1 |
0.7 |
5.0 |
1.0 |
5.1 |
1.1 |
7.8 |
1.0 |
Obesity |
Yes |
453 |
4.0 |
0.9 |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
13.8 |
3.1 |
No |
1,007 |
3.0 |
0.5 |
2.4 |
0.7 |
3.9 |
0.8 |
3.5 |
0.8 |
5.2 |
1.0 |
5.2 |
1.1 |
7.2 |
0.9 |
Cerebrovascular disease |
Yes |
DSU |
DSU |
DSU |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
No |
1,355 |
3.1 |
0.5 |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
CHF/pulmonary edema |
Yes |
DSU |
DSU |
DSU |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
No |
1,395 |
3.0 |
0.5 |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
COPD |
Yes |
DSU |
DSU |
DSU |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
No |
1,321 |
3.1 |
0.5 |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Smoking |
Yes |
DSU |
DSU |
DSU |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
No |
1,273 |
3.1 |
0.5 |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Corticosteroids |
Yes |
DSU |
DSU |
DSU |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
No |
1,431 |
3.2 |
0.5 |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Coronary artery disease |
Yes |
261 |
4.6 |
1.3 |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
No |
1,199 |
3.0 |
0.5 |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Renal disease |
Yes |
DSU |
DSU |
DSU |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
No |
1,385 |
3.2 |
0.5 |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Steroids |
Yes |
DNA |
DNA |
DNA |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
No |
DNA |
DNA |
DNA |
2.2 |
0.6 |
4.1 |
0.8 |
3.2 |
0.7 |
5.1 |
0.9 |
5.9 |
1.0 |
8.1 |
0.9 |
a. Data were not collected in 2008. The 2002-2007 data include Medicare beneficiaries discharged from January to December and the 2009 data include Medicare beneficiaries discharged from January to September.
DNA - Data have not been analyzed.
DSU - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.
Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.
Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.